Panagiotis Malandrakis, MD (he/him/his)

Scientific associate
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Athens, Greece

Panagiotis Malandrakis, MD

Clinical and Research Fellow
Plasma Cell Dyscrasias Unit
Section of Hematology and Medical Oncology
Department of Clinical Therapeutics
School of Medicine
National and Kapodistrian University of Athens
Alexandra Hospital
80 Vasilissis Sophias, 11528, Athens, Greece

Presentation(s):

• OA-14: Persistent bone marrow and imaging MRD negativity may guide the duration of lenalidomide maintenance following ASCT in patients with multiple myeloma

  Wednesday, September 27, 2023
  4:30 PM – 4:40 PM EEST